Related Experiment Video
Updated: Aug 14, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
In Silico Structure-Guided Design of Peptide Candidates Targeting γ-Secretase Subunit Assembly
Selcen Arı Yuka1,2, Kübra Telli3, Alper Yılmaz4
1Department of Bioengineering, Yildiz Technical University, Istanbul, Turkey.
Abstract:
The γ-secretase complex is a membrane-embedded protease essential for intramembrane cleavage of substrates such as Notch receptors and the amyloid precursor protein (APP), processes central to cancer progression and Alzheimer's disease (AD) pathology. However, catalytic inhibition of γ-secretase disrupts multiple signaling pathways, resulting in dose-limiting toxicities. In this study, we report a structure-guided approach to generate peptides with binding and stability profiles that disrupt the assembly of γ-secretase by targeting the interactions of Presenilin-1 and Nicastrin with APH1. First, molecular docking was performed for 36 248 peptides of varying lengths to assess their affinity scores to the PS1 and NCT interaction regions of APH1. Peptides filtered based on their affinity scores and physicochemical properties were then subjected to global molecular docking. 50-nanosecond molecular dynamics simulations and MM/PBSA analyses were performed on the top 10 potential candidates, identifying those with high dynamic interaction potential. Thus, seven γ-secretase inhibitor candidates with favorable affinity scores capable of providing stable interactions and thereby having the potential to disrupt the APH1:PS1 assembly were identified. This approach, which overcomes the challenges of targeting the transmembrane catalytic domain, is based on the inhibition of subunit assembly and presents promising candidates for future experimental studies.
Insights
Researchers developed novel peptides to inhibit the γ-secretase complex by disrupting its assembly, offering a new therapeutic strategy for Alzheimer's disease (AD) and cancer. This approach avoids toxicities associated with direct catalytic inhibition.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- The γ-secretase complex is crucial for cleaving substrates like Notch receptors and amyloid precursor protein (APP).
- Dysregulation of these processes is linked to Alzheimer's disease (AD) and cancer.
- Direct catalytic inhibition of γ-secretase leads to dose-limiting toxicities due to pathway disruption.
Purpose of the Study:
- To develop novel peptide inhibitors that target γ-secretase assembly rather than its catalytic activity.
- To identify peptides that disrupt the interactions between Presenilin-1 (PS1) and Nicastrin (NCT) with APH1.
Main Methods:
- Structure-guided design and molecular docking of over 36,000 peptides.
- Filtering peptides based on affinity scores and physicochemical properties.
- Molecular dynamics simulations and MM/PBSA analyses for top candidates.
Main Results:
- Identified seven peptide candidates with favorable affinity scores for APH1.
- These peptides demonstrated stable interactions, suggesting potential to disrupt APH1:PS1 assembly.
- The study successfully identified inhibitors targeting subunit assembly, bypassing challenges of catalytic domain inhibition.
Conclusions:
- A novel structure-guided approach successfully identified peptides inhibiting γ-secretase assembly.
- These peptides represent promising candidates for therapeutic development in AD and cancer.
- Inhibiting subunit assembly offers a safer alternative to direct catalytic inhibition of γ-secretase.
More Related Videos
06:40Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
Published on: January 25, 2018
11:09Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation
Published on: August 1, 2018